EXPRESSION OF THE NEU PROTOONCOGENE BY SCHWANN-CELLS DURING PERIPHERAL-NERVE DEVELOPMENT AND WALLERIAN DEGENERATION

被引:105
作者
COHEN, JA
YACHNIS, AT
ARAI, M
DAVIS, JG
SCHERER, SS
机构
[1] UNIV PENN, SCH MED, DEPT NEUROL, PHILADELPHIA, PA 19104 USA
[2] UNIV PENN, SCH MED, DEPT PATHOL & LAB MED, PHILADELPHIA, PA 19104 USA
关键词
ONCOGENE; GROWTH FACTORS; MYELINATION;
D O I
10.1002/jnr.490310406
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The neu gene, which encodes a putative tyrosine kinase growth factor receptor termed p185neu, was originally identified as a dominant transforming gene in neurogliomas and schwannomas induced by transplacental treatment of rat embryos with ethylnitrosourea. The present studies were undertaken to determine the expression pattern of the neu gene in peripheral nerve. Northern blot analysis of total RNA isolated from rat sciatic nerves demonstrated prominent neu mRNA expression on postnatal days 1 and 7, with substantially lower expression up to adulthood. Immunohistochemical studies confirmed expression of p185neu by Schwann cells (SC) in developing sciatic nerve and minimal p185neu immunoreactivity in adult nerves. However, neu mRNA and p185neu protein progressively increased following sciatic nerve transection in adult animals. In addition, neu mRNA and p185neu were found in neonatal rat sciatic nerve SC and several SC-derived cell lines. In resting SC, neu mRNA was expressed at a low level, but was greatly increased by treatment with forskolin and glial growth factor. These studies demonstrate that the neu gene and its protein product, p185neu, are expressed by SC both in vivo and in vitro and suggest that p185neu plays a role in the regulation of SC proliferation or differentiation.
引用
收藏
页码:622 / 634
页数:13
相关论文
共 82 条
[1]   TUMOR PROMOTER AND EPIDERMAL GROWTH-FACTOR STIMULATE PHOSPHORYLATION OF THE C-ERBB-2-GENE PRODUCT IN MKN-7 HUMAN ADENOCARCINOMA CELLS [J].
AKIYAMA, T ;
SAITO, T ;
OGAWARA, H ;
TOYOSHIMA, K ;
YAMAMOTO, T .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (03) :1019-1026
[2]  
Asbury AK, 1978, PATHOLOGY PERIPHERAL
[3]   INCREASED TYROSINE KINASE-ACTIVITY ASSOCIATED WITH THE PROTEIN ENCODED BY THE ACTIVATED NEU ONCOGENE [J].
BARGMANN, CI ;
WEINBERG, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (15) :5394-5398
[4]   THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
NATURE, 1986, 319 (6050) :226-230
[5]   MULTIPLE INDEPENDENT ACTIVATIONS OF THE NEU ONCOGENE BY A POINT MUTATION ALTERING THE TRANSMEMBRANE DOMAIN OF P185 [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
CELL, 1986, 45 (05) :649-657
[6]  
BERGER MS, 1988, CANCER RES, V48, P1238
[7]  
BRADLEY W G, 1970, Experimental Neurology, V26, P275, DOI 10.1016/0014-4886(70)90125-1
[8]  
BROCKES JP, 1987, METHOD ENZYMOL, V147, P217
[9]   SCHWANN-CELL PROLIFERATION IN THE POSTNATAL MOUSE - TIMING AND TOPOGRAPHY [J].
BROWN, MJ ;
ASBURY, AK .
EXPERIMENTAL NEUROLOGY, 1981, 74 (01) :170-186
[10]   EVIDENCE FOR FUNCTIONAL DOMAINS ON THE REOVIRUS TYPE-3 HEMAGGLUTININ [J].
BURSTIN, SJ ;
SPRIGGS, DR ;
FIELDS, BN .
VIROLOGY, 1982, 117 (01) :146-155